advancements in immunotherapy for high-risk hr breast cancer
Published 1 month ago • 64 plays • Length 3:05Download video MP4
Download video MP3
Similar videos
-
1:23
latest advances in immuno-oncology research in er breast cancer
-
1:30
exploring endocrine therapy innovations for high-risk hormone receptor-positive breast cancer
-
6:54
key clinical trials investigating immunotherapy in her2 and hr breast cancer
-
0:34
future role of immunotherapy in her2 breast cancer
-
1:28
the evolution of immunotherapy for breast cancer
-
2:05
immunotherapy in breast cancer
-
4:03
monarche 4-year: abemaciclib endocrine therapy for hr , her2-, node-positive, high-risk early bc
-
1:39
encouraging developments in triple negative breast cancer immunotherapy
-
7:26
i-spy 2: immunotherapy biomarkers in early breast cancer
-
1:30
emerging immunotherapy beyond checkpoint inhibitors for tnbc
-
1:08
the role of immunotherapy in endocrine-refractory luminal breast cancer
-
4:11
immunotherapy for tnbc: impassion130 & keynote-355
-
1:46
ctdna and late recurrence in high-risk, hr , her2- breast cancer
-
2:30
impassion130: immunotherapy for tnbc
-
1:20
advances in immunotherapy for non-melanoma skin cancer
-
46:20
immunotherapy for breast and pancreatic cancers, with elizabeth jaffee
-
5:32
esmo 2020 expert video report on cdk4 6i in the adjuvant treatment of breast cancer
-
1:01
the future therapeutic landscape of immunotherapy for mtnbc
-
26:14
metastatic breast cancer | 2022 oneoncology conference